Aptose Biosciences (APTO)
(Delayed Data from NSDQ)
$1.22 USD
+0.06 (5.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.24 +0.02 (1.64%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.82 |
EPS Last Quarter | -1.44 |
Last EPS Surprise | 2.70% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.31 |
Next Year | -3.11 |
EPS (TTM) | -7.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.82 | -0.77 | -3.31 | -3.11 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.84 | -0.94 | -3.89 | NA |
High Estimate | -0.80 | -0.59 | -2.73 | -3.11 |
Low Estimate | -0.84 | -0.94 | -3.89 | -3.11 |
Year ago EPS | -2.25 | -2.27 | -7.58 | -3.31 |
Year over Year Growth Est. | 63.56% | 66.08% | 56.33% | 6.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.82 | -0.77 | -3.31 | -3.11 |
7 Days Ago | -0.82 | -0.77 | -3.31 | -3.11 |
30 Days Ago | -0.86 | -0.83 | -3.45 | NA |
60 Days Ago | -0.88 | -0.72 | -3.00 | NA |
90 Days Ago | -1.60 | -1.76 | -5.67 | -3.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.82 | -0.77 | -3.31 | -3.11 |
Zacks Consensus Estimate | -0.82 | -0.77 | -3.31 | -3.11 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.44 | -1.76 | -2.27 | -2.25 | NA |
Estimate | -1.48 | -2.16 | -2.09 | -1.80 | NA |
Difference | 0.04 | 0.40 | -0.18 | -0.45 | -0.05 |
Surprise | 2.70% | 18.52% | -8.61% | -25.00% | -3.10% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more